Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells

J Immunol. 2004 Dec 15;173(12):7223-9. doi: 10.4049/jimmunol.173.12.7223.

Abstract

MHC class I-specific inhibitory receptors are expressed by a subset of memory-phenotype CD8(+) T cells. Similar to NK cells, MHC class I-specific inhibitory receptors might subserve on T cells an important negative control that participates to the prevention of autologous damage. We analyzed here human CD8(+) T cells that express the Ig-like MHC class I-specific inhibitory receptors: killer cell Ig-like receptor (KIR) and CD85j. The cell surface expression of Ig-like inhibitory MHC class I receptors was found to correlate with an advanced stage of CD8(+) T cell maturation as evidenced by the reduced proliferative potential of KIR(+) and CD85j(+) T cells associated with their high intracytoplasmic perforin content. This concomitant regulation might represent a safety mechanism to control potentially harmful cytolytic CD8(+) T cells, by raising their activation threshold. Yet, KIR(+) and CD85j(+) T cells present distinct features. KIR(+)CD8(+) T cells are poor IFN-gamma producers upon TCR engagement. In addition, KIR are barely detectable at the surface of virus-specific T cells during the course of CMV or HIV-1 infection. By contrast, CD85j(+)CD8(+) T cells produce IFN-gamma upon TCR triggering, and represent a large fraction of virus-specific T cells. Thus, the cell surface expression of Ig-like inhibitory MHC class I receptors is associated with T cell engagement into various stages of the cytolytic differentiation pathway, and the cell surface expression of CD85j or KIR witnesses to the history of qualitatively and/or quantitatively distinct T cell activation events.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / biosynthesis*
  • Antigens, CD / blood
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / metabolism*
  • CD8-Positive T-Lymphocytes / virology
  • Cell Proliferation
  • Clone Cells
  • Cytomegalovirus Infections / immunology
  • Cytotoxicity Tests, Immunologic
  • Cytotoxicity, Immunologic*
  • HIV-1 / immunology
  • Histocompatibility Antigens Class I / immunology*
  • Humans
  • Immunologic Memory
  • Immunophenotyping
  • Kidney Transplantation / adverse effects
  • Kidney Transplantation / immunology
  • Leukocyte Immunoglobulin-like Receptor B1
  • Lymphocyte Activation / immunology
  • Male
  • Receptors, Antigen, T-Cell / biosynthesis
  • Receptors, Immunologic / biosynthesis*
  • Receptors, Immunologic / blood
  • Receptors, KIR

Substances

  • Antigens, CD
  • Histocompatibility Antigens Class I
  • LILRB1 protein, human
  • Leukocyte Immunoglobulin-like Receptor B1
  • Receptors, Antigen, T-Cell
  • Receptors, Immunologic
  • Receptors, KIR